![4-Chloropyrrolo[2,3-d]-pyrimidine](https://img.chemicalbook.in/ProductImageIndia/2024-03/Large/c9632791-a4bc-4cfd-8353-6250f7373cad.png)
![4-Chloropyrrolo[2,3-d]-pyrimidine](https://img.chemicalbook.in/ProductImageIndia/2024-03/Small/c9632791-a4bc-4cfd-8353-6250f7373cad.png)
![4-Chloropyrrolo[2,3-d]-pyrimidine](https://img.chemicalbook.in/ProductImageIndia/2024-03/Small/a8c45c14-2614-48e1-b446-8810e881a1fd.png)
4-Chloropyrrolo[2,3-d]-pyrimidine 98%
| Price | Get Latest Price | |||
| Packge | 1kg | 5kg | 10kg | 25kg |
- Min. Order:10kg
- Time:2024-01-05
Product Details
- Product Name4-Chloropyrrolo[2,3-d]-pyrimidine
- EINECS No.628-079-2
- MFC6H4ClN3
- MW153.57
- AppearanceCrystalline PowderWhite to tan
- Melting point 188-194 °C
- storage temp. Keep in dark place,Inert atmosphere,2-8°C
- Boiling point 289.2±50.0 °C(Predicted)
- density 1.61±0.1 g/cm3(Predicted)
Company Profile Introduction
AbilityPharma is a clinical-stage biopharmaceutical company focused on developing first-in-class fully differentiated oral targeted anticancer compounds that produces autophagy-mediated cytotoxicity selectively in cancer cells.
The first drug candidate, ABTL0812, is currently in phase 2b clinical trials in pancreatic cancer in Spain, USA, France, and Israel. The product has also completed with positive results a phase 2a trial in endometrial cancer and squamous non-small cell lung cancer in Spain and France.
The phase 2a trial in endometrial cancer and lung cancer was conducted in Vall d’Hebron Institute of Oncology (VHIO, Barcelona), Institut Gustave Roussy (Paris), Centre Léon-Bérard (Lyon), Institut Català d’Oncologia (ICO, L'Hospitalet, Badalona and Girona), INCLIVA (Valencia), Institut Paoli-Calmettes (Marseille) and Hospital Universitario Virgen del Rocío (Sevilla)
Supplier other products
Recommended supplier
-
VIP1年
- SOLFYN INTERNATIONAL LLP
- 3680-69-1 4-chloro-7H-pyrrolo[2 ,3- d]pyrimidine 99%
- Inquiry
- 2024-12-03
-
VIP1年
- SETV ASRV LLP
- 3680-69-1 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine 95-99 %
- Inquiry
- 2024-09-11
-
VIP1年
- Mekanar Pharma Private Limited
- 3680-69-1 99%
- Inquiry
- 2024-05-22
-
VIP1年
- Actis Generics Pvt Ltd
- 3680-69-1 4-Chloropyrrolo[2,3-d]-pyrimidine 98%
- Inquiry
- 2024-03-20
-
VIP1年
- Prodev Pharma Pvt Ltd
- 4-Chloropyrrolo[2,3-d]-pyrimidine 3680-69-1 98%
- Inquiry
- 2024-03-16
-
VIP1年
- Dr. Jagath Reddy's Heterocyclics
- 3680-69-1 98%
- Inquiry
- 2024-03-01
-
VIP1年
- Clarity Research Laboratory
- 3680-69-1 4-Chloropyrrolo[2,3-d]-pyrimidine 99%
- Inquiry
- 2024-02-20
-
VIP1年
- Telangana Pharmatech
- 4-Chloropyrrolo[2,3-d]-pyrimidine 3680-69-1 98%
- Inquiry
- 2024-01-29
-
VIP1年
- Rivashaa Agrotech Biopharma Pvt. Ltd.
- 4-Chloropyrrolo[2,3-d]-pyrimidine 98%
- Inquiry
- 2024-01-25
-
VIP1年
- Synergene Active Ingredients Pvt. Ltd.
- 3680-69-1 98%
- Inquiry
- 2024-01-17
- Since:2020-01-01
- Address: Survey No. 285, KK Owners Association, IDA Doolapally, Jeedimetla, Hyderabad, Telangana-500 055, Ind